Bl. Gulson et al., CONTRIBUTION OF TISSUE LEAD TO BLOOD LEAD IN ADULT FEMALE SUBJECTS BASED ON STABLE LEAD-ISOTOPE METHODS, The Journal of laboratory and clinical medicine, 125(6), 1995, pp. 703-712
Citations number
34
Categorie Soggetti
Medical Laboratory Technology","Medicine, General & Internal
Public health and medical recommendations on prevention of lead toxici
ty rely on use of blood lead concentrations to assess lead exposure an
d predict onset of adverse health effects. Blood lead levels have gene
rally been thought to reflect recent environmental lead exposures. How
ever, tissue lead stores are accumulated over a long time period (i.e.
, years). These tissue stores, primarily from bone, can be remobilized
as part of both normal physiologic and pathologic processes. Although
chemical analyses do not differentiate lead isotopes, mass spectromet
ric determinations can differentiate the quantities of stable lead iso
topes present in particular samples (e.g., lead 207, lead 206, lead 20
4, and lead 208) Selected geographic locations may have distinct isoto
pic profiles. For example, on mainland Australia the Pb-206 Pb-204 rat
ios reported in both environmental lead sources and blood samples are
typically less than 17.0. By contrast, stable lead isotope profiles in
blood samples of adult women immigrating from Eastern Europe and the
former Soviet Union usually have Pb-206/Pb-204 ratios greater than 47.
5 and as high as 18.5 on entry into Australia. Longitudinal monitoring
of blood samples to determine stable lead isotope profiles by mass sp
ectrometry and chemical analyses of blood samples for total lead conte
nt were conducted over a 300-day period. These data show that between
45% and 70% of lead in blood comes from long-term tissue lead stores.
Recognition that the predominant source of lead in blood was tissue st
ores rather than the contemporaneous environment should greatly modify
recommendations on use of blood lead to monitor occupational or envir
onmental interventions. In addition, internal biokinetics of lead, doc
umented through presence of tissue lead in blood, underlie the long-te
rm health risks of lead exposure. Transfer of lead to the fetus from m
aternal tissue stores represents a special area of concern.